In addition, the hIL-7-hFc protein not hIL-7 was shown to enhance genital mucosal CD8+ T cell immune responses to the human papillomavirus (HPV) GX188 DNA vaccine and promote the anti-tumor activity of the vaccine (159). This evidence concerns the gene CD8A and neoplasm.